{"ticker": {"uuid": "27663c7a-6dcd-4181-93e1-6c576387cb45", "symbol": "ZLAB", "name": "Zai Lab Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Director adds Zai Lab (ZLAB) ADS under pre-set Rule 10b5-1 plan", "summary": "Zai Lab Ltd director Richard Gaynor purchased 1,736 American Depositary Shares (ADS) on July 1, 2026, at $19.05 per ADS through an open-market transaction. This purchase was pre-scheduled under a Rule 10b5-1 trading plan adopted on December 16, 2025. Following the transaction, Ga", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-79eeb2fb2abc.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:40:08", "published_display": "06 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) CEO Du Ying gains ADSs from RSU awards and tax withholding", "summary": "Zai Lab Ltd's CEO, Du Ying, engaged in compensation-related equity activity involving American Depositary Shares (ADSs) and Restricted Share Units (RSUs) on July 1\u20132, 2026. She acquired 29,048 ADSs through RSU exercises and had 11,431 ADSs withheld to cover tax obligations. Addit", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-bfa6263acc8f.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:40:08", "published_display": "06 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) CEO sells ADS to cover taxes after RSU vesting", "summary": "Zai Lab Ltd's Chairperson & CEO, Du Ying, reported routine equity compensation activity involving American Depositary Shares (ADSs). Du Ying exercised Restricted Share Units (RSUs) for 17,970 ADSs and subsequently sold 7,026 ADSs at $18.534 each to cover tax obligations. After th", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-ae857c6bdf72.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:35", "published_display": "01 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Zai Lab Ltd For: 30 June By Investing.com", "summary": "This article announces the filing of Form 144 for Zai Lab Ltd for the period ending June 30. It provides a brief update on this specific financial filing, without offering further details on the content of the form. The article is very concise and primarily serves as a notificati", "url": "https://ng.investing.com/news/stock-market-news/form-144-zai-lab-ltd-for-30-june-93CH-2580731", "source_name": "Investing.com Nigeria", "published_at": "2026-07-01T08:40:35", "published_display": "01 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ: ZLAB) insider resale planned on 06/29/2026; recent ADS sales reported", "summary": "A ZLAB Form 144 filing reports a proposed resale of American Depositary Shares (ADS) linked to a Restricted Stock Vesting event scheduled for June 29, 2026. The filing also discloses multiple recent dispositions of ADS by an insider, Ying Du, between April 2, 2026, and June 26, 2", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-9c252522811a.html", "source_name": "Stock Titan", "published_at": "2026-06-30T19:13:55", "published_display": "30 Jun 2026 19:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) legal chief settles RSUs, sells ADSs for taxes", "summary": "Zai Lab's Chief Legal Officer, Edmondson Frazor Titus III, settled 14,600 Restricted Share Units (RSUs) into American Depositary Shares (ADSs) on June 25, 2026, as part of his compensation vesting schedule. The following day, 4,103 of these ADSs were sold at an average price of $", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-5367952fcb6f.html", "source_name": "Stock Titan", "published_at": "2026-06-30T08:10:34", "published_display": "30 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) CEO sells ADSs after RSU vesting and tax cover", "summary": "Zai Lab's Chairperson and CEO, Ying Du, sold 24,543 American Depositary Shares (ADSs) for $17.461 each on June 26, 2026, to cover tax obligations following the vesting of 58,800 Restricted Share Units (RSUs) on June 25, 2026. After these transactions, Du directly owns 1,192,840 A", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-a51f200772aa.html", "source_name": "Stock Titan", "published_at": "2026-06-29T21:09:12", "published_display": "29 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Zai Lab Ltd. \u2013 HKEX:9688", "summary": "This article provides a financial metric, specifically the enterprise value to revenue forward, for Zai Lab Ltd., traded on the Hong Kong Exchange under the ticker HKEX:9688. It highlights that the market was closed and no trades were made at the time of the report. The content a", "url": "https://www.tradingview.com/symbols/HKEX-9688/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T20:39:46", "published_display": "29 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CFO equity transactions at Zai Lab (ZLAB) show RSU vesting and tax sale", "summary": "Zai Lab's CFO, Yajing Chen, reported equity compensation activity where 6,250 Restricted Share Units (RSUs) vested into American Depositary Shares (ADSs). Subsequently, 2,264 of these ADSs were automatically sold to cover tax obligations. Following these transactions, Chen direct", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-8207a957f526.html", "source_name": "Stock Titan", "published_at": "2026-06-29T20:09:55", "published_display": "29 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks", "summary": "This article lists various ETFs that include Zai Lab Ltd. Sponsored ADR stocks in their holdings. It provides detailed financial information for each ETF, such as market value, weight of Zai Lab shares, issuer, management style, focus, expense ratio, AUM, price changes, and histo", "url": "https://www.tradingview.com/symbols/NASDAQ-ZLAB/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T10:40:34", "published_display": "29 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Zai Lab Ltd. \u2013 HKEX:9688", "summary": "The article provides information regarding the \"Price to earnings forward\" metric for Zai Lab Ltd. (HKEX:9688), a biotechnology company listed on the Hong Kong Exchange. It presents a specific value for this financial metric during an unspecified period and details its change and", "url": "https://www.tradingview.com/symbols/HKEX-9688/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T12:10:15", "published_display": "28 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:ZLAB)", "summary": "This article provides an overview of Zai Lab Limited (NASDAQ: ZLAB) with a focus on its financial actuals, estimates, and analyst forecasts available on TradingView. It highlights where users can explore reported financial data, compare actual results with average, high, and low ", "url": "https://www.tradingview.com/symbols/NASDAQ-ZLAB/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-28T07:39:47", "published_display": "28 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Sponsored ADR Actuals & Estimates (GETTEX:1ZL)", "summary": "This page on TradingView provides an overview of Zai Lab Ltd. Sponsored ADR (GETTEX:1ZL), focusing on its actual financial data and analyst estimates. Users can explore reported financial data across income statements, balance sheets, and cash flow statements, comparing actual re", "url": "https://www.tradingview.com/symbols/GETTEX-1ZL/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-28T03:09:59", "published_display": "28 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ) director files to sell 2,264 ADS after vesting", "summary": "Zai Lab Ltd (ZLAB) has filed a Form 144 to report a proposed sale of 2,264 American Depositary Shares (ADS) following the vesting of restricted stock on June 25, 2026. This notice also details previous ADS dispositions by Yajing Chen on April 2, 2026, and April 6, 2026, for 5,199", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-a53515f1a0dd.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ: ZLAB) Form 144 shows Ying Du ADS sales and vesting event", "summary": "Zai Lab Ltd (ZLAB) has filed a Form 144 detailing insider sales of American Depositary Shares (ADS) by Ying Du. The filing indicates 24,543 ADS are to be sold for an associated dollar figure of $428,552.69, and also records past sales by Ying Du between April and May 2026. These ", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-2f38e10768b1.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ: ZLAB) director files Form 144 to sell 4,103 ADS on vesting", "summary": "Zai Lab Ltd (NASDAQ: ZLAB) director filed a Form 144 to sell 4,103 American Depositary Shares (ADS) due to restricted stock vesting on June 25, 2026. This filing also details previous ADS dispositions by Frazor T. Edmondson on April 2, April 6, and May 14, 2026. The Form 144 is a", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-eb3e6f240c26.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Actuals & Estimates (HKEX:9688)", "summary": "This article provides an overview of Zai Lab Ltd. (HKEX:9688) stock performance, financial estimates, and key metrics. It covers the current stock price, historical highs and lows, analyst forecasts, volatility, market capitalization, and upcoming earnings reports, offering a com", "url": "https://www.tradingview.com/symbols/HKEX-9688/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Actuals & Estimates (LS:A3DJSH)", "summary": "This article provides financial actuals and estimates for Zai Lab Ltd. (A3DJSH), including its current stock price, analyst forecasts, historical highs and lows, market capitalization, and upcoming earnings reports. It details financial metrics like revenue, net income, and EBITD", "url": "https://www.tradingview.com/symbols/LS-A3DJSH/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T08:09:41", "published_display": "26 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Zai Lab Ltd. \u2013 HKEX:9688", "summary": "This article provides access to the forward Price to Sales ratio for Zai Lab Ltd. (HKEX:9688) through the TradingView platform. It details how users can view this financial metric along with other financial information for the company. The page also outlines various features and ", "url": "https://www.tradingview.com/symbols/HKEX-9688/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:09:40", "published_display": "26 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB/N Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a price target forecast for Zai Lab Ltd. Sponsored ADR (ZLAB/N) for 2027 based on analysis from 13 analysts. The current price target is 579.34, with no specific maximum or minimum estimates provided, and includes sections for annual and quarterly EPS and re", "url": "https://www.tradingview.com/symbols/BMV-ZLAB/N/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T19:42:24", "published_display": "25 Jun 2026 19:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) director Lis sells 7,040 ADS under 10b5-1 plan", "summary": "Zai Lab Ltd director William Lis sold 7,040 American Depositary Shares (ADS) at $18.09 each in an open-market transaction, following a Rule 10b5-1 trading plan established on September 10, 2025. After the sale, Lis directly holds 50,437 ADS. Each ADS represents ten Ordinary Share", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-a396fd76fd2b.html", "source_name": "Stock Titan", "published_at": "2026-06-24T19:39:44", "published_display": "24 Jun 2026 19:39", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) director receives 22,371 ADS stock award, now holds 79,001 ADSs", "summary": "Richard Gaynor, a director at Zai Lab (ZLAB), was granted 22,371 American Depositary Shares (ADSs) as a compensation award on June 17, 2026. This award increased his direct holdings to 79,001 ADSs. The granted shares are restricted and will fully vest on June 17, 2027, provided G", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-25fbc8172ba0.html", "source_name": "Stock Titan", "published_at": "2026-06-23T18:09:41", "published_display": "23 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) director receives 22,371 ADS equity award", "summary": "Zai Lab Ltd director Nisa Leung was granted 22,371 American Depositary Shares (ADS) as compensation, boosting her direct holdings to 96,297 ADS. These restricted shares will fully vest on June 17, 2027, provided she continues her service on the board. The grant was reported in a ", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-faeac2ec5277.html", "source_name": "Stock Titan", "published_at": "2026-06-23T18:09:41", "published_display": "23 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director William Lis receives 22,371 ADS award at Zai Lab (NASDAQ: ZLAB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOQ2dVX0M2UVFVZHhhcE9VLWJRX1FuTFZTUlRvdjVPdDhBUFFvMFZ0SW1mQVBjeFpXM1JtUF80WDhJbUpJZUxBSE9BSUxISFhqcGpIVlBUV0h6S3hYcUphVDZSNXBqLTZaYzg2bnhfT0VsVGdyWEdCYU9tU0JQMUhZMEl6cU1NclZZVVQ5QmZBaDhDQ3BuV2VOWmZnM2w3d01fZG9KTzhJbnU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zai Lab Limited (NASDAQ:ZLAB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOcmN6bm8tRzZSMFVHeVFMZmNuSWhCTVJqQlJLMnc2SVFaWFpPWjAzYzlURGhWQWJiVHJjTy0zQ3c3S1hBMDdDb0tUODJzYWZVM204dnhTUnNDSlI0SmpXc0lTQU1ld3cwTGM0bzBoZXBOeW9fVEFjSmxON0ltMmZLYkwxLW1GMG5xSFAwRGlldElqdlpjaEEw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Director adds Zai Lab (ZLAB) ADS under pre-set Rule 10b5-1 plan", "summary": "Zai Lab Ltd director Richard Gaynor purchased 1,736 American Depositary Shares (ADS) on July 1, 2026, at $19.05 per ADS through an open-market transaction. This purchase was pre-scheduled under a Rule 10b5-1 trading plan adopted on December 16, 2025. Following the transaction, Ga", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-79eeb2fb2abc.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:40:08", "published_display": "06 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) CEO Du Ying gains ADSs from RSU awards and tax withholding", "summary": "Zai Lab Ltd's CEO, Du Ying, engaged in compensation-related equity activity involving American Depositary Shares (ADSs) and Restricted Share Units (RSUs) on July 1\u20132, 2026. She acquired 29,048 ADSs through RSU exercises and had 11,431 ADSs withheld to cover tax obligations. Addit", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-bfa6263acc8f.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:40:08", "published_display": "06 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) CEO sells ADS to cover taxes after RSU vesting", "summary": "Zai Lab Ltd's Chairperson & CEO, Du Ying, reported routine equity compensation activity involving American Depositary Shares (ADSs). Du Ying exercised Restricted Share Units (RSUs) for 17,970 ADSs and subsequently sold 7,026 ADSs at $18.534 each to cover tax obligations. After th", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-ae857c6bdf72.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:40:35", "published_display": "01 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Zai Lab Ltd For: 30 June By Investing.com", "summary": "This article announces the filing of Form 144 for Zai Lab Ltd for the period ending June 30. It provides a brief update on this specific financial filing, without offering further details on the content of the form. The article is very concise and primarily serves as a notificati", "url": "https://ng.investing.com/news/stock-market-news/form-144-zai-lab-ltd-for-30-june-93CH-2580731", "source_name": "Investing.com Nigeria", "published_at": "2026-07-01T08:40:35", "published_display": "01 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ: ZLAB) insider resale planned on 06/29/2026; recent ADS sales reported", "summary": "A ZLAB Form 144 filing reports a proposed resale of American Depositary Shares (ADS) linked to a Restricted Stock Vesting event scheduled for June 29, 2026. The filing also discloses multiple recent dispositions of ADS by an insider, Ying Du, between April 2, 2026, and June 26, 2", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-9c252522811a.html", "source_name": "Stock Titan", "published_at": "2026-06-30T19:13:55", "published_display": "30 Jun 2026 19:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) legal chief settles RSUs, sells ADSs for taxes", "summary": "Zai Lab's Chief Legal Officer, Edmondson Frazor Titus III, settled 14,600 Restricted Share Units (RSUs) into American Depositary Shares (ADSs) on June 25, 2026, as part of his compensation vesting schedule. The following day, 4,103 of these ADSs were sold at an average price of $", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-5367952fcb6f.html", "source_name": "Stock Titan", "published_at": "2026-06-30T08:10:34", "published_display": "30 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) CEO sells ADSs after RSU vesting and tax cover", "summary": "Zai Lab's Chairperson and CEO, Ying Du, sold 24,543 American Depositary Shares (ADSs) for $17.461 each on June 26, 2026, to cover tax obligations following the vesting of 58,800 Restricted Share Units (RSUs) on June 25, 2026. After these transactions, Du directly owns 1,192,840 A", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-a51f200772aa.html", "source_name": "Stock Titan", "published_at": "2026-06-29T21:09:12", "published_display": "29 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Zai Lab Ltd. \u2013 HKEX:9688", "summary": "This article provides a financial metric, specifically the enterprise value to revenue forward, for Zai Lab Ltd., traded on the Hong Kong Exchange under the ticker HKEX:9688. It highlights that the market was closed and no trades were made at the time of the report. The content a", "url": "https://www.tradingview.com/symbols/HKEX-9688/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T20:39:46", "published_display": "29 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CFO equity transactions at Zai Lab (ZLAB) show RSU vesting and tax sale", "summary": "Zai Lab's CFO, Yajing Chen, reported equity compensation activity where 6,250 Restricted Share Units (RSUs) vested into American Depositary Shares (ADSs). Subsequently, 2,264 of these ADSs were automatically sold to cover tax obligations. Following these transactions, Chen direct", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-8207a957f526.html", "source_name": "Stock Titan", "published_at": "2026-06-29T20:09:55", "published_display": "29 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks", "summary": "This article lists various ETFs that include Zai Lab Ltd. Sponsored ADR stocks in their holdings. It provides detailed financial information for each ETF, such as market value, weight of Zai Lab shares, issuer, management style, focus, expense ratio, AUM, price changes, and histo", "url": "https://www.tradingview.com/symbols/NASDAQ-ZLAB/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T10:40:34", "published_display": "29 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Zai Lab Ltd. \u2013 HKEX:9688", "summary": "The article provides information regarding the \"Price to earnings forward\" metric for Zai Lab Ltd. (HKEX:9688), a biotechnology company listed on the Hong Kong Exchange. It presents a specific value for this financial metric during an unspecified period and details its change and", "url": "https://www.tradingview.com/symbols/HKEX-9688/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T12:10:15", "published_display": "28 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Sponsored ADR Actuals & Estimates (NASDAQ:ZLAB)", "summary": "This article provides an overview of Zai Lab Limited (NASDAQ: ZLAB) with a focus on its financial actuals, estimates, and analyst forecasts available on TradingView. It highlights where users can explore reported financial data, compare actual results with average, high, and low ", "url": "https://www.tradingview.com/symbols/NASDAQ-ZLAB/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-28T07:39:47", "published_display": "28 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Sponsored ADR Actuals & Estimates (GETTEX:1ZL)", "summary": "This page on TradingView provides an overview of Zai Lab Ltd. Sponsored ADR (GETTEX:1ZL), focusing on its actual financial data and analyst estimates. Users can explore reported financial data across income statements, balance sheets, and cash flow statements, comparing actual re", "url": "https://www.tradingview.com/symbols/GETTEX-1ZL/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-28T03:09:59", "published_display": "28 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ) director files to sell 2,264 ADS after vesting", "summary": "Zai Lab Ltd (ZLAB) has filed a Form 144 to report a proposed sale of 2,264 American Depositary Shares (ADS) following the vesting of restricted stock on June 25, 2026. This notice also details previous ADS dispositions by Yajing Chen on April 2, 2026, and April 6, 2026, for 5,199", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-a53515f1a0dd.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ: ZLAB) Form 144 shows Ying Du ADS sales and vesting event", "summary": "Zai Lab Ltd (ZLAB) has filed a Form 144 detailing insider sales of American Depositary Shares (ADS) by Ying Du. The filing indicates 24,543 ADS are to be sold for an associated dollar figure of $428,552.69, and also records past sales by Ying Du between April and May 2026. These ", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-2f38e10768b1.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB (NASDAQ: ZLAB) director files Form 144 to sell 4,103 ADS on vesting", "summary": "Zai Lab Ltd (NASDAQ: ZLAB) director filed a Form 144 to sell 4,103 American Depositary Shares (ADS) due to restricted stock vesting on June 25, 2026. This filing also details previous ADS dispositions by Frazor T. Edmondson on April 2, April 6, and May 14, 2026. The Form 144 is a", "url": "https://www.stocktitan.net/sec-filings/ZLAB/144-zai-lab-ltd-sec-filing-eb3e6f240c26.html", "source_name": "Stock Titan", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Actuals & Estimates (HKEX:9688)", "summary": "This article provides an overview of Zai Lab Ltd. (HKEX:9688) stock performance, financial estimates, and key metrics. It covers the current stock price, historical highs and lows, analyst forecasts, volatility, market capitalization, and upcoming earnings reports, offering a com", "url": "https://www.tradingview.com/symbols/HKEX-9688/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T19:10:50", "published_display": "26 Jun 2026 19:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Ltd. Actuals & Estimates (LS:A3DJSH)", "summary": "This article provides financial actuals and estimates for Zai Lab Ltd. (A3DJSH), including its current stock price, analyst forecasts, historical highs and lows, market capitalization, and upcoming earnings reports. It details financial metrics like revenue, net income, and EBITD", "url": "https://www.tradingview.com/symbols/LS-A3DJSH/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T08:09:41", "published_display": "26 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Zai Lab Ltd. \u2013 HKEX:9688", "summary": "This article provides access to the forward Price to Sales ratio for Zai Lab Ltd. (HKEX:9688) through the TradingView platform. It details how users can view this financial metric along with other financial information for the company. The page also outlines various features and ", "url": "https://www.tradingview.com/symbols/HKEX-9688/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:09:40", "published_display": "26 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ZLAB/N Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a price target forecast for Zai Lab Ltd. Sponsored ADR (ZLAB/N) for 2027 based on analysis from 13 analysts. The current price target is 579.34, with no specific maximum or minimum estimates provided, and includes sections for annual and quarterly EPS and re", "url": "https://www.tradingview.com/symbols/BMV-ZLAB/N/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T19:42:24", "published_display": "25 Jun 2026 19:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) director Lis sells 7,040 ADS under 10b5-1 plan", "summary": "Zai Lab Ltd director William Lis sold 7,040 American Depositary Shares (ADS) at $18.09 each in an open-market transaction, following a Rule 10b5-1 trading plan established on September 10, 2025. After the sale, Lis directly holds 50,437 ADS. Each ADS represents ten Ordinary Share", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-a396fd76fd2b.html", "source_name": "Stock Titan", "published_at": "2026-06-24T19:39:44", "published_display": "24 Jun 2026 19:39", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) director receives 22,371 ADS stock award, now holds 79,001 ADSs", "summary": "Richard Gaynor, a director at Zai Lab (ZLAB), was granted 22,371 American Depositary Shares (ADSs) as a compensation award on June 17, 2026. This award increased his direct holdings to 79,001 ADSs. The granted shares are restricted and will fully vest on June 17, 2027, provided G", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-25fbc8172ba0.html", "source_name": "Stock Titan", "published_at": "2026-06-23T18:09:41", "published_display": "23 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab (ZLAB) director receives 22,371 ADS equity award", "summary": "Zai Lab Ltd director Nisa Leung was granted 22,371 American Depositary Shares (ADS) as compensation, boosting her direct holdings to 96,297 ADS. These restricted shares will fully vest on June 17, 2027, provided she continues her service on the board. The grant was reported in a ", "url": "https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-faeac2ec5277.html", "source_name": "Stock Titan", "published_at": "2026-06-23T18:09:41", "published_display": "23 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director William Lis receives 22,371 ADS award at Zai Lab (NASDAQ: ZLAB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOQ2dVX0M2UVFVZHhhcE9VLWJRX1FuTFZTUlRvdjVPdDhBUFFvMFZ0SW1mQVBjeFpXM1JtUF80WDhJbUpJZUxBSE9BSUxISFhqcGpIVlBUV0h6S3hYcUphVDZSNXBqLTZaYzg2bnhfT0VsVGdyWEdCYU9tU0JQMUhZMEl6cU1NclZZVVQ5QmZBaDhDQ3BuV2VOWmZnM2w3d01fZG9KTzhJbnU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Limited (NASDAQ:ZLAB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPd25xX3FUa2c3eTZPRDUzTzdJNVU1eXdQYXk5clpwNlhWOW5LNjdVd1ZzeXhNejRVOExLUzdVSHMwUWQ5RXZoM240bzhPSWJJTDlUemlfVGVnQlMzSmFSeHNKazNCcFVPRl8tblR3cHluck9xS29td1RrOUY0TlJ2cXNVYV9xejN3SzlmR1RfVjRHc3ZYUk9TRkx4c2M5N2ZzV1hqZVdiNm5IQlFnbE1xYmo4eE00b1VHVnpYN3R2MGtjMk13SWpGY1hfN29jbXhDMzRBb0N0bUfSAd4BQVVfeXFMTWItOFFkZjNaRXJrNnZ3WmswVExIdXJYTDNwS0prYXNXRUV5MGNXQ3R1X0xMY0wwTzRuaDlUdl9MNmE2UHZFWV9ya1RFZUFqeHd4cG5fbEZfZmtkR2hCRXdRTERIMndndkd2LUtsQ3pGQ1ZZOHRyUjlzYkNEVXc3QTFmYmRlbzNfbUFaX0dzMThGR3pTRWNXb0dCUC1oUzV3RUhUcDVhWUdWeWcta0I2U3BSMTZSSnpObGh2MDYzMUp1LUl5ZkhqNklKb0s5SllJQW1BdDJZQk5JXzQxMGpB?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOcmN6bm8tRzZSMFVHeVFMZmNuSWhCTVJqQlJLMnc2SVFaWFpPWjAzYzlURGhWQWJiVHJjTy0zQ3c3S1hBMDdDb0tUODJzYWZVM204dnhTUnNDSlI0SmpXc0lTQU1ld3cwTGM0bzBoZXBOeW9fVEFjSmxON0ltMmZLYkwxLW1GMG5xSFAwRGlldElqdlpjaEEw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 96, "total_relevant": 35, "sentiment_summary": {"positive": 3, "negative": 4, "neutral": 28, "score": 50, "total": 35, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 11.0, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 6.6, "count": 14}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 20.49, "latest_week": "2026-07-10", "one_week_move": 7.2, "four_week_move": 20.0, "twelve_week_move": -15.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.079046, "market_dynamics_buy_signal": false, "relative_strength": -25.760173, "fair_value_gap": -16.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 43.8394, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+7.2% over one week, +20.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 14}, {"label": "TradingView", "count": 10}, {"label": "Market source", "count": 6}, {"label": "simplywall.st", "count": 4}, {"label": "Investing.com Nigeria", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 27}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Earnings", "count": 14}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "27", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+7.2% over one week, +20.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Director adds Zai Lab (ZLAB) ADS under pre-set Rule 10b5-1 plan"}], "updated_at": "2026-07-16T08:52:11.046247+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}